Global and Japan Crispr Genomic Cure Market Size, Status and Forecast 2021-2027

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Crispr Genomic Cure Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 gRNA Design and Vector Construction
  • 1.2.3 Cell Line and Engineering
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Crispr Genomic Cure Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Biomedical
  • 1.3.3 Pharmaceutical
  • 1.3.4 Agricultural
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Crispr Genomic Cure Market Perspective (2016-2027)
• 2.2 Crispr Genomic Cure Growth Trends by Regions
  • 2.2.1 Crispr Genomic Cure Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Crispr Genomic Cure Historic Market Share by Regions (2016-2021)
  • 2.2.3 Crispr Genomic Cure Forecasted Market Size by Regions (2022-2027)
• 2.3 Crispr Genomic Cure Industry Dynamic
  • 2.3.1 Crispr Genomic Cure Market Trends
  • 2.3.2 Crispr Genomic Cure Market Drivers
  • 2.3.3 Crispr Genomic Cure Market Challenges
  • 2.3.4 Crispr Genomic Cure Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Crispr Genomic Cure Players by Revenue
  • 3.1.1 Global Top Crispr Genomic Cure Players by Revenue (2016-2021)
  • 3.1.2 Global Crispr Genomic Cure Revenue Market Share by Players (2016-2021)
• 3.2 Global Crispr Genomic Cure Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Crispr Genomic Cure Revenue
• 3.4 Global Crispr Genomic Cure Market Concentration Ratio
  • 3.4.1 Global Crispr Genomic Cure Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Crispr Genomic Cure Revenue in 2020
• 3.5 Crispr Genomic Cure Key Players Head office and Area Served
• 3.6 Key Players Crispr Genomic Cure Product Solution and Service
• 3.7 Date of Enter into Crispr Genomic Cure Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Crispr Genomic Cure Breakdown Data by Type

• 4.1 Global Crispr Genomic Cure Historic Market Size by Type (2016-2021)
• 4.2 Global Crispr Genomic Cure Forecasted Market Size by Type (2022-2027)

5 Crispr Genomic Cure Breakdown Data by Application

• 5.1 Global Crispr Genomic Cure Historic Market Size by Application (2016-2021)
• 5.2 Global Crispr Genomic Cure Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Crispr Genomic Cure Market Size (2016-2027)
• 6.2 North America Crispr Genomic Cure Market Size by Type
  • 6.2.1 North America Crispr Genomic Cure Market Size by Type (2016-2021)
  • 6.2.2 North America Crispr Genomic Cure Market Size by Type (2022-2027)
  • 6.2.3 North America Crispr Genomic Cure Market Size by Type (2016-2027)
• 6.3 North America Crispr Genomic Cure Market Size by Application
  • 6.3.1 North America Crispr Genomic Cure Market Size by Application (2016-2021)
  • 6.3.2 North America Crispr Genomic Cure Market Size by Application (2022-2027)
  • 6.3.3 North America Crispr Genomic Cure Market Size by Application (2016-2027)
• 6.4 North America Crispr Genomic Cure Market Size by Country
  • 6.4.1 North America Crispr Genomic Cure Market Size by Country (2016-2021)
  • 6.4.2 North America Crispr Genomic Cure Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Crispr Genomic Cure Market Size (2016-2027)
• 7.2 Europe Crispr Genomic Cure Market Size by Type
  • 7.2.1 Europe Crispr Genomic Cure Market Size by Type (2016-2021)
  • 7.2.2 Europe Crispr Genomic Cure Market Size by Type (2022-2027)
  • 7.2.3 Europe Crispr Genomic Cure Market Size by Type (2016-2027)
• 7.3 Europe Crispr Genomic Cure Market Size by Application
  • 7.3.1 Europe Crispr Genomic Cure Market Size by Application (2016-2021)
  • 7.3.2 Europe Crispr Genomic Cure Market Size by Application (2022-2027)
  • 7.3.3 Europe Crispr Genomic Cure Market Size by Application (2016-2027)
• 7.4 Europe Crispr Genomic Cure Market Size by Country
  • 7.4.1 Europe Crispr Genomic Cure Market Size by Country (2016-2021)
  • 7.4.2 Europe Crispr Genomic Cure Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Crispr Genomic Cure Market Size (2016-2027)
• 8.2 Asia-Pacific Crispr Genomic Cure Market Size by Type
  • 8.2.1 Asia-Pacific Crispr Genomic Cure Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Crispr Genomic Cure Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Crispr Genomic Cure Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Crispr Genomic Cure Market Size by Application
  • 8.3.1 Asia-Pacific Crispr Genomic Cure Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Crispr Genomic Cure Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Crispr Genomic Cure Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Crispr Genomic Cure Market Size by Region
  • 8.4.1 Asia-Pacific Crispr Genomic Cure Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Crispr Genomic Cure Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Crispr Genomic Cure Market Size (2016-2027)
• 9.2 Latin America Crispr Genomic Cure Market Size by Type
  • 9.2.1 Latin America Crispr Genomic Cure Market Size by Type (2016-2021)
  • 9.2.2 Latin America Crispr Genomic Cure Market Size by Type (2022-2027)
  • 9.2.3 Latin America Crispr Genomic Cure Market Size by Type (2016-2027)
• 9.3 Latin America Crispr Genomic Cure Market Size by Application
  • 9.3.1 Latin America Crispr Genomic Cure Market Size by Application (2016-2021)
  • 9.3.2 Latin America Crispr Genomic Cure Market Size by Application (2022-2027)
  • 9.3.3 Latin America Crispr Genomic Cure Market Size by Application (2016-2027)
• 9.4 Latin America Crispr Genomic Cure Market Size by Country
  • 9.4.1 Latin America Crispr Genomic Cure Market Size by Country (2016-2021)
  • 9.4.2 Latin America Crispr Genomic Cure Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Crispr Genomic Cure Market Size (2016-2027)
• 10.2 Middle East & Africa Crispr Genomic Cure Market Size by Type
  • 10.2.1 Middle East & Africa Crispr Genomic Cure Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Crispr Genomic Cure Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Crispr Genomic Cure Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Crispr Genomic Cure Market Size by Application
  • 10.3.1 Middle East & Africa Crispr Genomic Cure Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Crispr Genomic Cure Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Crispr Genomic Cure Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Crispr Genomic Cure Market Size by Country
  • 10.4.1 Middle East & Africa Crispr Genomic Cure Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Crispr Genomic Cure Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Abcam
  • 11.1.1 Abcam Company Details
  • 11.1.2 Abcam Business Overview
  • 11.1.3 Abcam Crispr Genomic Cure Introduction
  • 11.1.4 Abcam Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.1.5 Abcam Recent Development
• 11.2 Applied StemCel
  • 11.2.1 Applied StemCel Company Details
  • 11.2.2 Applied StemCel Business Overview
  • 11.2.3 Applied StemCel Crispr Genomic Cure Introduction
  • 11.2.4 Applied StemCel Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.2.5 Applied StemCel Recent Development
• 11.3 Beam Therapeutics
  • 11.3.1 Beam Therapeutics Company Details
  • 11.3.2 Beam Therapeutics Business Overview
  • 11.3.3 Beam Therapeutics Crispr Genomic Cure Introduction
  • 11.3.4 Beam Therapeutics Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.3.5 Beam Therapeutics Recent Development
• 11.4 CALYXT
  • 11.4.1 CALYXT Company Details
  • 11.4.2 CALYXT Business Overview
  • 11.4.3 CALYXT Crispr Genomic Cure Introduction
  • 11.4.4 CALYXT Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.4.5 CALYXT Recent Development
• 11.5 Cellecta
  • 11.5.1 Cellecta Company Details
  • 11.5.2 Cellecta Business Overview
  • 11.5.3 Cellecta Crispr Genomic Cure Introduction
  • 11.5.4 Cellecta Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.5.5 Cellecta Recent Development
• 11.6 Cellectis
  • 11.6.1 Cellectis Company Details
  • 11.6.2 Cellectis Business Overview
  • 11.6.3 Cellectis Crispr Genomic Cure Introduction
  • 11.6.4 Cellectis Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.6.5 Cellectis Recent Development
• 11.7 CRISPR Therapeutics AG
  • 11.7.1 CRISPR Therapeutics AG Company Details
  • 11.7.2 CRISPR Therapeutics AG Business Overview
  • 11.7.3 CRISPR Therapeutics AG Crispr Genomic Cure Introduction
  • 11.7.4 CRISPR Therapeutics AG Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.7.5 CRISPR Therapeutics AG Recent Development
• 11.8 Editas Medicine
  • 11.8.1 Editas Medicine Company Details
  • 11.8.2 Editas Medicine Business Overview
  • 11.8.3 Editas Medicine Crispr Genomic Cure Introduction
  • 11.8.4 Editas Medicine Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.8.5 Editas Medicine Recent Development
• 11.9 ERS ​​Genomics
  • 11.9.1 ERS ​​Genomics Company Details
  • 11.9.2 ERS ​​Genomics Business Overview
  • 11.9.3 ERS ​​Genomics Crispr Genomic Cure Introduction
  • 11.9.4 ERS ​​Genomics Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.9.5 ERS ​​Genomics Recent Development
• 11.10 Integrated DNA Technologies
  • 11.10.1 Integrated DNA Technologies Company Details
  • 11.10.2 Integrated DNA Technologies Business Overview
  • 11.10.3 Integrated DNA Technologies Crispr Genomic Cure Introduction
  • 11.10.4 Integrated DNA Technologies Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.10.5 Integrated DNA Technologies Recent Development
• 11.11 Intellia Therapeutics
  • 11.11.1 Intellia Therapeutics Company Details
  • 11.11.2 Intellia Therapeutics Business Overview
  • 11.11.3 Intellia Therapeutics Crispr Genomic Cure Introduction
  • 11.11.4 Intellia Therapeutics Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.11.5 Intellia Therapeutics Recent Development
• 11.12 Merck KGaA
  • 11.12.1 Merck KGaA Company Details
  • 11.12.2 Merck KGaA Business Overview
  • 11.12.3 Merck KGaA Crispr Genomic Cure Introduction
  • 11.12.4 Merck KGaA Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.12.5 Merck KGaA Recent Development
• 11.13 New England Biolabs
  • 11.13.1 New England Biolabs Company Details
  • 11.13.2 New England Biolabs Business Overview
  • 11.13.3 New England Biolabs Crispr Genomic Cure Introduction
  • 11.13.4 New England Biolabs Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.13.5 New England Biolabs Recent Development
• 11.14 Precision BioSciences
  • 11.14.1 Precision BioSciences Company Details
  • 11.14.2 Precision BioSciences Business Overview
  • 11.14.3 Precision BioSciences Crispr Genomic Cure Introduction
  • 11.14.4 Precision BioSciences Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.14.5 Precision BioSciences Recent Development
• 11.15 Sangamo Therapeutics
  • 11.15.1 Sangamo Therapeutics Company Details
  • 11.15.2 Sangamo Therapeutics Business Overview
  • 11.15.3 Sangamo Therapeutics Crispr Genomic Cure Introduction
  • 11.15.4 Sangamo Therapeutics Revenue in Crispr Genomic Cure Business (2016-2021)
  • 11.15.5 Sangamo Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer